US Patent Issued to Beth Israel Deaconess Medical Center, Aalborg University, Resalis Therapeutics on July 28 for "Inhibitors of micro-RNA 22" (Danish, American Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,135, issued on July 28, was assigned to Beth Israel Deaconess Medical Center (Boston), Aalborg University (Aalborg, Denmark) and Resalis Therapeutics srl (Turin, Italy).

"Inhibitors of micro-RNA 22" was invented by Pier Paolo Pandolfi (Boston), Riccardo Panella (Boston), Sakari Kauppinen (Aalborg, Denmark) and Andreas Petri (Aalborg, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions and methods that inhibit the activity of microRNAs, for example miR-22."

The patent was filed on Oct. 12, 2022, under Application No. 18/045,906.

*For further information, including images, charts and tables, please vis...